Outsourcing a rare or orphan disease program means finding CRO and CDMO partners who can work where patients are few and scattered: disease-specific or engineered models, natural history and registry studies, biomarker-based eligibility, novel or surrogate endpoints, advocacy-group access, and decentralized trial elements. On BioBridgeX, buyers source and compare qualified suppliers across discovery, preclinical, and clinical work as the neutral marketplace, free for buyers, then contract directly with their chosen supplier.
Rare / Orphan Disease CRO and CDMO vendors (168)
UNIQ Trials
Apeloa Pharmaceutical
TRiCBIO
VCHP Clinical Solutions
AAPharmaSyn
Singota Solutions
CDMO · Aseptic Fill-Finish, Drug Product Manufacturing, QC & Release Testing
Symbiosis Pharmaceutical Services
CDMO · Aseptic Fill-Finish, Drug Product Manufacturing, QC & Release Testing
Grand River Aseptic Manufacturing (GRAM)
CDMO · Formulation Development, LNP / Delivery Formulation, Process Development
Simtra BioPharma Solutions
CDMO · Formulation Development, LNP / Delivery Formulation, Process Development
Vetter Pharma
CDMO · Formulation Development, LNP / Delivery Formulation, Process Development
PCI Pharma Services
CDMO · Aseptic Fill-Finish, Drug Product Manufacturing, Formulation Development
BSP Pharmaceuticals
CDMO · ADC / Bioconjugation, Aseptic Fill-Finish, Drug Product Manufacturing
WuXi STA (STA Pharmaceutical)
CDMO · Peptide / Oligo Synthesis, Drug Substance: Small Molecule / API, ADC / Bioconjugation
CPC Scientific
CDMO · Peptide / Oligo Synthesis, Process Development, Analytical Development
Senn Chemicals (Granules India)
CDMO · Peptide / Oligo Synthesis, Process Development, Analytical Development
Recipharm
CDMO · mRNA / RNA Manufacturing, LNP / Delivery Formulation, Drug Product Manufacturing
Phosphorex
CDMO · LNP / Delivery Formulation, Formulation Development, Process Development
Ascendia Pharmaceutical Solutions
CDMO · LNP / Delivery Formulation, Formulation Development, Drug Product Manufacturing
Acuitas Therapeutics
CDMO · LNP / Delivery Formulation, Formulation Development, Process Development
Genevant Sciences
CDMO · LNP / Delivery Formulation, Formulation Development, Process Development
Evonik (Health Care)
CDMO · LNP / Delivery Formulation, Formulation Development, Drug Product Manufacturing
Merck Millipore (MilliporeSigma / Sigma-Aldrich CTDMO)
CDMO · mRNA / RNA Manufacturing, LNP / Delivery Formulation, Plasmid DNA Manufacturing
Fujifilm (Toyama Chemical / FUJIFILM Diosynth LNP)
CDMO · mRNA / RNA Manufacturing, LNP / Delivery Formulation, Aseptic Fill-Finish
Ajinomoto Bio-Pharma Services
CRO & CDMO · Peptide / Oligo Synthesis, ADC / Bioconjugation, Drug Substance: Small Molecule / API
CSBio
CDMO · Peptide / Oligo Synthesis, Process Development, Analytical Development
Bio-Synthesis Inc
CDMO · Peptide / Oligo Synthesis, mRNA / RNA Manufacturing, ADC / Bioconjugation
Northern RNA
CDMO · mRNA / RNA Manufacturing, LNP / Delivery Formulation, Plasmid DNA Manufacturing
TriLink BioTechnologies (Maravai LifeSciences)
CDMO · mRNA / RNA Manufacturing, Peptide / Oligo Synthesis, Process Development
Polymun Scientific
CDMO · LNP / Delivery Formulation, mRNA / RNA Manufacturing, Formulation Development
Agilent Technologies
CDMO · Peptide / Oligo Synthesis, Process Development, Analytical Development
ST Pharm
CDMO · Peptide / Oligo Synthesis, mRNA / RNA Manufacturing, Process Development
Nitto Avecia Pharma Services
CDMO · Peptide / Oligo Synthesis, Process Development, Analytical Development
WuXi TIDES (WuXi AppTec)
CRO & CDMO · Peptide / Oligo Synthesis, ADC / Bioconjugation, Medicinal & Synthetic Chemistry
Kaneka Eurogentec
CDMO · Peptide / Oligo Synthesis, Plasmid DNA Manufacturing, Drug Substance: Biologics
PolyPeptide Group
CDMO · Peptide / Oligo Synthesis, Process Development, Analytical Development
Advanced BioScience Laboratories (ABL)
CDMO · Viral Vector Manufacturing, Process Development, Analytical Development
Merck KGaA (MilliporeSigma / Sigma-Aldrich CTDMO)
CRO & CDMO · Viral Vector Manufacturing, Cell Therapy Manufacturing, mRNA / RNA Manufacturing
Vernal Biosciences
CDMO · mRNA / RNA Manufacturing, LNP / Delivery Formulation, Plasmid DNA Manufacturing
Ascend Advanced Therapies
CDMO · Viral Vector Manufacturing, Process Development, Analytical Development
IDT Biologika
CDMO · Viral Vector Manufacturing, Process Development, Analytical Development
Vibalogics (ReciBioPharm / Recipharm)
CDMO · Viral Vector Manufacturing, Process Development, Analytical Development
VectorBuilder
CRO & CDMO · Viral Vector Manufacturing, Plasmid DNA Manufacturing, Process Development
Pharmaron (Biologics / CGT)
CRO & CDMO · Viral Vector Manufacturing, Plasmid DNA Manufacturing, Cell Therapy Manufacturing
Esco Aster
CDMO · Viral Vector Manufacturing, Plasmid DNA Manufacturing, Cell Therapy Manufacturing
3PBIOVIAN (3P Biopharmaceuticals + Biovian)
CDMO · Viral Vector Manufacturing, Plasmid DNA Manufacturing, Cell Therapy Manufacturing
Eurogentec (Kaneka)
CDMO · Plasmid DNA Manufacturing, Peptide / Oligo Synthesis, mRNA / RNA Manufacturing
PackGene Biotech
CRO & CDMO · Viral Vector Manufacturing, Plasmid DNA Manufacturing, mRNA / RNA Manufacturing
SK pharmteco
CDMO · Viral Vector Manufacturing, Plasmid DNA Manufacturing, Cell Therapy Manufacturing
The Center for Breakthrough Medicines
CDMO · Viral Vector Manufacturing, Cell Therapy Manufacturing, Plasmid DNA Manufacturing
ElevateBio BaseCamp
CDMO · Cell Therapy Manufacturing, Viral Vector Manufacturing, Process Development
RoslinCT
CDMO · Cell Therapy Manufacturing, Process Development, Analytical Development
Minaris Advanced Therapies
CDMO · Cell Therapy Manufacturing, Viral Vector Manufacturing, Process Development
Genezen
CDMO · Viral Vector Manufacturing, Cell Therapy Manufacturing, Plasmid DNA Manufacturing
Viralgen (AskBio)
CDMO · Viral Vector Manufacturing, Process Development, Analytical Development
Andelyn Biosciences
CDMO · Viral Vector Manufacturing, Plasmid DNA Manufacturing, Process Development
Forge Biologics (Ajinomoto)
CDMO · Viral Vector Manufacturing, Plasmid DNA Manufacturing, Process Development
Aldevron (Danaher)
CDMO · Plasmid DNA Manufacturing, mRNA / RNA Manufacturing, Process Development
National Resilience
CDMO · Viral Vector Manufacturing, Cell Therapy Manufacturing, mRNA / RNA Manufacturing
FUJIFILM Biotechnologies (formerly FUJIFILM Diosynth)
CDMO · Viral Vector Manufacturing, Cell Therapy Manufacturing, Process Development
Oxford Biomedica
CDMO · Viral Vector Manufacturing, Plasmid DNA Manufacturing, Process Development
WuXi Advanced Therapies
CRO & CDMO · Viral Vector Manufacturing, Cell Therapy Manufacturing, Plasmid DNA Manufacturing
Catalent
CDMO · Viral Vector Manufacturing, Cell Therapy Manufacturing, Plasmid DNA Manufacturing
Aldevron
CDMO · Process Development, Analytical Development, Plasmid DNA Manufacturing
Polpharma Biologics
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
Bora Biologics
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
Binex
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
GenScript ProBio
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
Bionova Scientific
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
Wacker Biotech
CDMO · Process Development, Analytical Development, Drug Substance: Biologics
Richter BioLogics (Richter-Helm)
CDMO · Process Development, Analytical Development, Drug Substance: Biologics
3PBIOVIAN
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
Avid Bioservices
CDMO · Process Development, Analytical Development, Drug Substance: Biologics
Cytovance Biologics
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
GBI (Goodwin Biotechnology)
CDMO · Process Development, Analytical Development, Drug Substance: Biologics
BioVectra
CDMO · Process Development, Analytical Development, Drug Substance: Biologics
ProBioGen
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
Just - Evotec Biologics
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
Northway Biotech
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
Wheeler Bio
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
Rentschler Biopharma
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
KBI Biopharma
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
AGC Biologics
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
FUJIFILM Diosynth Biotechnologies
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
Catalent Biologics
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
Boehringer Ingelheim BioXcellence
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
WuXi Biologics
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
Samsung Biologics
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
Almac Group
CRO & CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
Onyx Scientific (IPCA)
CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
Navin Molecular (Navin Fluorine)
CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
PROCOS
CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
Minakem (Minafin Group)
CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
Curia (formerly AMRI)
CRO & CDMO · Target ID & Validation, Hit-to-Lead, Lead Optimization
Bachem
CDMO · Peptide / Oligo Synthesis, Process Development, Analytical Development
AMPAC Fine Chemicals (SK pharmteco)
CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
Veranova
CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
Pfizer CentreOne
CRO & CDMO · Drug Substance: Small Molecule / API, Process Development, Analytical Development
Thermo Fisher Scientific (Patheon)
CRO & CDMO · Process Development, Drug Substance: Small Molecule / API, Analytical Development
Piramal Pharma Solutions
CRO & CDMO · Hit-to-Lead, Lead Optimization, Medicinal & Synthetic Chemistry
EUROAPI
CDMO · Drug Substance: Small Molecule / API, Process Development, Analytical Development
Seqens
CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
Olon Group
CDMO · Drug Substance: Small Molecule / API, Process Development, Analytical Development
Hovione
CDMO · Drug Substance: Small Molecule / API, Process Development, Analytical Development
CordenPharma
CRO & CDMO · Drug Substance: Small Molecule / API, Process Development, Analytical Development
Sterling Pharma Solutions
CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
WuXi STA (WuXi AppTec)
CRO & CDMO · Medicinal & Synthetic Chemistry, Process Development, Analytical Development
Asymchem
CRO & CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
Siegfried
CDMO · Drug Substance: Small Molecule / API, Process Development, Analytical Development
Cambrex
CDMO · Drug Substance: Small Molecule / API, Process Development, Analytical Development
Lonza
CRO & CDMO · Drug Substance: Small Molecule / API, Process Development, Analytical Development
NorthEast BioLab
CRO · Bioanalytical Services, Immunogenicity & Immunotoxicology, Biomarker Discovery & Development
Synexa Life Sciences
CRO · Biomarker Discovery & Development, Bioanalytical Services, Immunogenicity & Immunotoxicology
Certara
CRO · PK/PD & Modeling, Biostatistics & Statistical Programming, Medical Writing
LabConnect
CRO · Central Laboratory Services, Biomarker Discovery & Development, Clinical Data Management
Labcorp
CRO & CDMO · Central Laboratory Services, GLP Toxicology, Safety Pharmacology
Q2 Solutions
CRO · Central Laboratory Services, Biomarker Discovery & Development, Bioanalytical Services
BioAgilytix Labs
CRO · Bioanalytical Services, Immunogenicity & Immunotoxicology, Biomarker Discovery & Development
GemPharmatech
CRO · In Vitro Pharmacology, Target ID & Validation, Biomarker Discovery & Development
XenTech
CRO · In Vitro Pharmacology, Biomarker Discovery & Development, PK/PD & Modeling
Labcorp (Labcorp Drug Development)
CRO · In Vitro Pharmacology, DMPK / ADME, GLP Toxicology
The Jackson Laboratory (JAX)
CRO · In Vitro Pharmacology, Biomarker Discovery & Development, Target ID & Validation
BenevolentAI
CRO · Target ID & Validation, Computational / AI-Driven Discovery
Insilico Medicine
CRO · Target ID & Validation, Hit-to-Lead, Lead Optimization
Recursion Pharmaceuticals
CRO · Target ID & Validation, Assay Development & Screening, Hit-to-Lead
Abzena
CRO & CDMO · Assay Development & Screening, Hit-to-Lead, Lead Optimization
Aurigene Pharmaceutical Services
CRO & CDMO · Target ID & Validation, Assay Development & Screening, Hit-to-Lead
Sygnature Discovery
CRO · Target ID & Validation, Assay Development & Screening, Hit-to-Lead
Syngene International
CRO & CDMO · GLP Toxicology, Safety Pharmacology, DMPK / ADME
Aragen Life Sciences
CRO & CDMO · DMPK / ADME, GLP Toxicology, Safety Pharmacology
Sai Life Sciences
CRO & CDMO · DMPK / ADME, In Vitro / Early Toxicology, GLP Toxicology
KCAS Bio
CRO · Bioanalytical Services, Biomarker Discovery & Development, Immunogenicity & Immunotoxicology
IQVIA Laboratories (Q2 Solutions)
CRO · Bioanalytical Services, Biomarker Discovery & Development, DMPK / ADME
Lovelace Biomedical
CRO · GLP Toxicology, Safety Pharmacology, Toxicokinetics (TK)
Vivotecnia
CRO · GLP Toxicology, Safety Pharmacology, Genetic Toxicology
BioAgilytix
CRO · Bioanalytical Services, Immunogenicity & Immunotoxicology, Biomarker Discovery & Development
Scantox
CRO · GLP Toxicology, Safety Pharmacology, Genetic Toxicology
Evotec
CRO & CDMO · In Vitro / Early Toxicology, DMPK / ADME, Safety Pharmacology
WuXi AppTec
CRO & CDMO · GLP Toxicology, Safety Pharmacology, Genetic Toxicology
Inotiv
CRO · GLP Toxicology, Safety Pharmacology, Genetic Toxicology
Labcorp (Labcorp Drug Development / former Covance)
CRO & CDMO · GLP Toxicology, Safety Pharmacology, Genetic Toxicology
Charles River Laboratories
CRO & CDMO · GLP Toxicology, Safety Pharmacology, Genetic Toxicology
Avance Clinical
CRO · Clinical Operations, Phase 1 / Early Clinical Unit, Clinical Data Management
TFS HealthScience
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Cytel
CRO · Biostatistics & Statistical Programming, Clinical Data Management, Clinical Operations
Precision for Medicine
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Pharmaron
CRO & CDMO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
WuXi Clinical
CRO · Clinical Operations, Phase 1 / Early Clinical Unit, Clinical Data Management
Tigermed
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
CMIC Group
CRO & CDMO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Linical
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
ClinChoice
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Emmes
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
ProPharma
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Novotech
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Premier Research
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Veristat
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Caidya
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Allucent
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
PSI CRO
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Worldwide Clinical Trials
CRO · Clinical Operations, Phase 1 / Early Clinical Unit, Clinical Data Management
Syneos Health
CRO · Clinical Operations, Phase 1 / Early Clinical Unit, Clinical Data Management
Medpace
CRO · Clinical Operations, Phase 1 / Early Clinical Unit, Clinical Data Management
Fortrea
CRO · Clinical Operations, Phase 1 / Early Clinical Unit, Clinical Data Management
PPD (Thermo Fisher Scientific)
CRO · Clinical Operations, Phase 1 / Early Clinical Unit, Clinical Data Management
Parexel
CRO · Clinical Operations, Phase 1 / Early Clinical Unit, Clinical Data Management
ICON plc
CRO · Clinical Operations, Phase 1 / Early Clinical Unit, Clinical Data Management
IQVIA
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
What kind of CRO work does a Rare / Orphan Disease program need?
Rare disease programs run the same arc as any other (discovery, preclinical, IND-enabling, then clinical) but almost every step bends around one fact: there are very few patients, and they are spread across countries and centers of excellence rather than concentrated where a CRO has standing sites. That shapes what you outsource and who you can outsource it to.
On the discovery and preclinical side, the live problem is often that a relevant disease model does not exist off the shelf. Many rare conditions are monogenic, so the work leans on genetic models: knock-in or knockout animals carrying the patient mutation, patient-derived iPSC lines, or humanized models built for a specific defect. A CRO that runs standard oncology xenografts may have never touched the model your program needs, so you are sourcing for a specific capability, not a category. Around that sit the usual pharmacology, DMPK, and GLP toxicology studies, with extra weight on biomarker work because a measurable readout of target engagement is often what makes a small trial interpretable at all.
Clinical is where rare disease diverges hardest from common-indication trial design. Natural history studies frequently come first, because for many orphan conditions nobody has cleanly documented how the disease progresses untreated, and regulators increasingly expect that baseline. Patient registries, advocacy-group partnerships, and genetic screening feed recruitment, since you cannot run a hundred-site enrollment funnel when the worldwide population is in the hundreds. Trials tend to use novel or surrogate endpoints (a validated biomarker, a functional scale, an imaging measure) rather than the hard outcomes a large oncology or cardiovascular study would use, and they often need decentralized elements like home nursing, local lab draws, and travel support so a family is not asked to fly to a site every visit. Both FDA Orphan Drug Designation and EMA orphan designation carry development incentives, and the CRO or regulatory supplier you pick should know how to build toward them.
How do you choose a CRO for Rare / Orphan Disease?
Therapeutic-area logos matter less here than specific, demonstrated experience in your disease or a closely related one. The question to keep asking is not "have you done rare disease" (almost everyone says yes) but "have you run a program in this exact condition, or one with the same model, endpoint, and recruitment problem." Use this checklist when you compare suppliers:
- Disease-specific experience: ask for programs in your indication or a near neighbor, named (not anonymized) where confidentiality allows, and what the endpoints and enrollment outcomes actually were.
- Relevant models or patient access: for preclinical, confirm the genetic or patient-derived model is already running in-house with historical control data. For clinical, confirm real relationships with the registries, advocacy groups, and centers of excellence where your patients are.
- Regulatory track record: experience securing Orphan Drug Designation, engaging the FDA's rare disease pathways, and supporting submissions that relied on small datasets, surrogate endpoints, or natural history as an external control.
- Endpoint and biomarker capability: a supplier who can develop or validate the functional scale, imaging measure, or biomarker your program depends on, not just run a generic EDC build.
- Data quality at small n: when a trial enrolls dozens rather than thousands, every subject and every data point carries weight, so monitoring rigor, source data verification, and clean CDISC-conformant datasets matter more, not less.
- Capacity and geographic reach: the ability to activate sites across the countries where your patients live, run decentralized or home-based visits, and handle the cross-border logistics a dispersed population forces.
Frequently asked questions
Why is finding patients the hardest part of a rare disease trial?
Do I need a natural history study before my interventional trial?
What is Orphan Drug Designation and does the CRO help me get it?
Will a generalist preclinical CRO have the disease model I need?
How does data quality work when the trial only has a few dozen patients?
How does BioBridgeX work for a rare disease program, and what does it cost me?
Source Rare / Orphan Disease work with one contract
Compare transparent quotes from qualified Rare / Orphan Disease CRO and CDMO vendors, then contract once. Free for buyers.
Compare quotes